Secretary for Health concludes visit to Hainan Province (with photos)
*********************************************************************
He said, "To align with the National 15th Five-Year Plan, Hong Kong is vigorously promoting the research and development (R&D) and application of biomedicine technologies. Through the Greater Bay Area International Clinical Trial Institute, the Real-World Study and Application Centre, and the upcoming establishment of the Hong Kong Centre for Medical Products Regulation within this year, Hong Kong will also further improve the mechanism for new drug R&D and approval, and provide comprehensive support for innovative drugs, spanning clinical trials, regulation and approval, and inclusion in the public healthcare system."
He also welcomed Mainland pharmaceutical companies to conduct clinical trials in Hong Kong, making full use of the unique advantages of the city to facilitate the translation and clinical application of advanced biomedicine technologies in Hong Kong, and leveraging Hong Kong as a platform for bringing innovative drugs to the international markets.
Prior to their departure from Hainan Province, the delegation met with officials of the Hong Kong and Macao Affairs Office of Hainan Province. Professor Lo briefed them on the latest developments in Hong Kong's healthcare policy areas.
Members of the delegation include the Director of Health, Dr Ronald Lam; the Senior Advisor (Secretary for Health's Office), Dr Joe Fan; the Director of the Real-World Study and Application Centre, Professor Cheung Ching-lung; as well as officers of the HHB, the Department of Health and the Hospital Authority. They concluded the visit and will return to Hong Kong this afternoon.
Ends/Friday, August 14, 2026
Issued at HKT 13:20
Issued at HKT 13:20
NNNN




